Token导航 LogoToken导航

Agent Skill · 研究检索

antibody-humanizer(抗体人源化剂)

antibody-humanizer 用于查找、检索和筛选相关信息,适合在 OpenClaw 中需要根据关键词、任务场景或来源线索快速定位候选结果时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

antibody-humanizer 是研究检索类 Agent Skill,可用宿主为 OpenClaw,通过ClawHub获取,权限为权限未标注;许可证为 MIT-0,第三方扫描已通过,按安装量在研究检索类的 73,674 个 Skill 里排第 20,725。

总安装 5,116周安装 209GitHub Stars 公开资料未说明下载 1,655核验 2026-05-01

安装说明

本站只整理中文说明,不托管安装包,也不代用户安装。
GitHub
许可证
MIT-0
版本
0.1.0

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:antibody-humanizer(抗体人源化剂)
来源仓库:https://github.com/aipoch-ai/antibody-humanizer
安装命令:
openclaw skills install antibody-humanizer
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 OpenClaw 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

ClawHubOpenClaw
openclaw skills install antibody-humanizer

这个 Skill 是做什么的

研究检索类 Skill 主要解决「找资料、核对事实、把来源整理清楚」的问题,通常会让助手先检索再总结。

antibody-humanizer 预测鼠源抗体人源化序列,降低免疫原性同时保留抗原结合能力。适用于 OpenClaw 中生物医药研发场景,支持 CDR 移植与框架优化策略。输出包含突变位点与稳定性评估的完整设计方案。使用前应确认是否涉及敏感基因数据处理,遵守相关科研伦理规范。

建议结合实验验证结果迭代模型参数,提高预测准确性。

上手步骤

4 步
  1. 1

    确认自己的宿主工具

    公开资料标注支持 OpenClaw;先确认自己用的是其中之一,再按对应工具的 Skills 目录放置。

  2. 2

    拿到安装命令

    可以直接复制的命令是 openclaw skills install antibody-humanizer;命令里的占位符换成自己的路径或密钥再执行。

  3. 3

    安装后重启宿主

    命令执行完要完全退出宿主工具再打开,让新装的 Skill 被重新扫描到,否则列表里可能看不到。

  4. 4

    按最小权限试用

    权限没有明确标注,第一次使用时只给一个无关紧要的任务,观察它到底读了哪些文件和网络。

常见问题

6 条

antibody-humanizer 怎么安装?

在终端执行 openclaw skills install antibody-humanizer。装完完全退出宿主工具再打开,让它重新扫描本地 Skill。

antibody-humanizer 支持哪些 AI 工具?

公开资料标注支持 OpenClaw。其他工具只要能读取本地 Skill 目录,一般也能手动放进去,但要自己确认触发方式是否一致。

antibody-humanizer 需要什么权限?

权限级别没有明确标注。第一次使用时建议只给无关紧要的任务,观察它实际读写了哪些内容。

antibody-humanizer 是免费的吗?

来源标注的许可证是 MIT-0。本站不代收任何费用,也不托管安装包;能否商用、要不要署名,以许可证原文为准。

antibody-humanizer 用的人多吗?

公开数据是累计安装 5,116 次,近一周安装 209 次,下载 1,655 次。这些数字来自第三方目录统计,只能当作热度参考,不代表质量或安全性。

antibody-humanizer 安全吗?

第三方扫描结果为通过,但这只覆盖已知的静态检查项,不能替代自己读一遍源码和安装命令。

值得选的地方和要先想清楚的地方

值得选的地方

  • 专注 OpenClaw 一种宿主,触发方式和使用习惯不用来回切换。
  • 许可证明确为 MIT-0,商用和分发边界好判断。
  • 第三方扫描已通过,常见的高风险行为没有命中。

先想清楚的地方

  • 第三方目录整理,版本更新和行为细节以来源仓库为准。

适不适合你

更适合

  • 已经在用 OpenClaw,想直接扩展它能力的人。
  • 需要处理研究检索类任务、又不想每次都手写提示词的人。
  • 需要许可证清楚、并且有第三方扫描结果的团队项目。

不太适合

  • 需要厂商级技术支持和 SLA 的生产系统。

研究检索类 Skill 对比

6 个同类
Skill总安装GitHub 星权限许可证扫描
find-skills

寻找技能 · Codex、Claude

31,199,81316,486操作浏览器MIT有提醒
self-improving-agent

自我改进 Agent · OpenClaw

16,464,0023,396接触敏感数据MIT-0通过
soultrace

灵魂追踪 · Codex、Claude

7,588,94412需要联网未明确有提醒
self-improving

自我完善 · OpenClaw

6,829,2841,046需要联网MIT-0通过
microsoft-foundry

微软代工厂 · Codex、Claude

6,614,144764调用外部服务未明确有提醒
antibody-humanizer

抗体人源化剂 · 本页

5,116—权限未标注MIT-0通过

按安装量取同分类前几名;数字来自第三方目录统计,只作热度参考,不代表质量结论。

SKILL.md 原文

name
antibody-humanizer
description
Humanize murine antibody sequences using CDR grafting and framework
allowed-tools
[Read, Write, Bash, Edit]
license
MIT
metadata
skill-author
AIPOCH

Antibody Humanizer

Overview

Bioinformatics platform for converting murine antibodies into humanized variants by grafting complementarity-determining regions (CDRs) onto human framework templates while preserving antigen-binding affinity and reducing immunogenicity risk.

Key Capabilities:

  • CDR Identification: Automatic CDR boundary detection (Kabat/Chothia/IMGT schemes)
  • Framework Matching: Database search for optimal human germline templates
  • Humanization Scoring: Multi-parameter immunogenicity risk assessment
  • Back-Mutation Prediction: Identify critical framework residues for retention
  • Batch Processing: Humanize multiple antibody candidates efficiently
  • Immunogenicity Assessment: T-cell epitope and humanness scoring

When to Use

✅ Use this skill when:

  • Converting murine hybridoma antibodies to therapeutic candidates
  • Reducing immunogenicity risk of rodent-derived antibodies
  • Selecting human framework templates for CDR grafting
  • Identifying critical framework residues for antigen binding
  • Comparing multiple humanization strategies for lead optimization
  • Preparing antibody sequences for patent filings
  • Teaching antibody engineering principles

❌ Do NOT use when:

  • Fully human antibody generation from phage display → Use phage-display-library
  • De novo antibody design → Use antibody-design-ai
  • Affinity maturation → Use affinity-maturation-predictor
  • ADCC/CDC optimization → Use fc-engineering-toolkit
  • Final therapeutic candidate selection → Requires experimental validation

Integration:

  • Upstream: antibody-sequencer (VH/VL sequence determination), cdr-grafting-validator (structural assessment)
  • Downstream: protein-struct-viz (3D visualization), immunogenicity-predictor (T-cell epitope analysis)

Core Capabilities

1. CDR Region Identification

Parse antibody sequences and identify CDR boundaries:

from scripts.humanizer import AntibodyHumanizer

humanizer = AntibodyHumanizer()

# Analyze antibody sequence
analysis = humanizer.analyze_sequence(
    vh_sequence="QVQLQQSGPELVKPGASVKISCKASGYTFTDYYMHWVKQSHGKSLEWIGYINPSTGYTEYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAR...",
    vl_sequence="DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYPYT...",
    scheme="chothia"  # Options: kabat, chothia, imgt
)

# Output CDR locations
print(analysis.cdr_regions)
# {
#   "VH_CDR1": {"start": 26, "end": 32, "seq": "GYTFTDY"},
#   "VH_CDR2": {"start": 52, "end": 58, "seq": "INPSTGY"},
#   ...
# }

Numbering Schemes:

SchemeVH CDR1VH CDR2VH CDR3Best For
Chothia26-3252-5695-102Structural analysis
Kabat31-3550-6595-102Sequence-based work
IMGT27-3856-65105-117Standardized analysis

2. Human Framework Matching

Identify optimal human germline templates:

# Match against human germline database
matches = humanizer.find_human_frameworks(
    vh_framework=analysis.vh_frameworks,
    vl_framework=analysis.vl_frameworks,
    top_n=5,
    criteria=["homology", "canonical_structure", "vernier_similarity"]
)

# Evaluate each candidate
for match in matches:
    print(f"Template: {match.germline_genes}")
    print(f"Homology: {match.homology:.2%}")
    print(f"Vernier Score: {match.vernier_score:.1f}")
    print(f"Risk Level: {match.immunogenicity_risk}")

Matching Criteria:

  • Sequence Homology: Percent identity to human germline
  • Canonical Structure: Loop conformation compatibility
  • Vernier Region: Framework residues contacting CDRs
  • Interface Residues: Packing interactions with CDRs

3. Humanization Scoring

Assess immunogenicity risk of candidates:

# Score humanization candidates
scores = humanizer.score_candidates(
    murine_antibody=analysis,
    human_templates=matches,
    scoring_methods=["t20", "h_score", "germline_deviation", "paratope_diversity"]
)

# Rank by overall score
ranked = scores.rank_by_composite_score(
    weights={"humanness": 0.4, "binding_retention": 0.4, "developability": 0.2}
)

Scoring Methods:

MethodDescriptionTarget
T20 Score20-mer peptide humanization>80% human
H-ScoreHummerblind germline distance<15 mutations
Paratope DiversityCDR germline gene diversityLow diversity
DevelopabilityAggregation/pH stability predictionHigh score

4. Back-Mutation Prediction

Identify critical residues to retain from murine framework:

# Predict back-mutations
back_mutations = humanizer.predict_back_mutations(
    murine_vh=analysis.vh_sequence,
    human_vh=matches[0].human_template,
    cdr_regions=analysis.cdr_regions,
    rationale_required=True
)

# Output shows position-specific recommendations
for mutation in back_mutations:
    print(f"Position {mutation.position}: {mutation.human_aa} → {mutation.murine_aa}")
    print(f"Rationale: {mutation.reason}")  # e.g., "Vernier region contact"
    print(f"Priority: {mutation.priority}")  # Critical/Important/Optional

Critical Residue Classes:

  • Vernier Positions: Framework residues contacting CDRs (VH 24, 71, 94)
  • Interface Packs: Residue packing between VH and VL
  • Canonical Anchors: Cysteines and conserved framework positions
  • Buried Positions: Core packing residues affecting stability

Common Patterns

Pattern 1: Standard Therapeutic Humanization

Scenario: Convert murine anti-tumor antibody to therapeutic candidate.

# Humanize single antibody
python scripts/main.py \
  --vh "QVQLQQSGPELVKPGASVKISCKAS..." \
  --vl "DIQMTQSPSSLSASVGDRVTITCRAS..." \
  --name "Anti-HER2-Murine-1" \
  --scheme chothia \
  --top-n 3 \
  --output humanization_report.json

# Review top candidates
cat humanization_report.json | jq '.candidates[0]'

Workflow:

  1. Input murine VH/VL sequences
  2. Identify CDRs using Chothia scheme
  3. Match to human germline database
  4. Score top 3 candidates
  5. Identify required back-mutations
  6. Output humanized sequences

Pattern 2: Batch Humanization Screening

Scenario: Screen multiple murine clones from hybridoma campaign.

# Process multiple antibodies
antibodies = [
    {"name": "Clone-A", "vh": "...", "vl": "..."},
    {"name": "Clone-B", "vh": "...", "vl": "..."},
    {"name": "Clone-C", "vh": "...", "vl": "..."}
]

results = humanizer.batch_humanize(
    antibodies=antibodies,
    ranking_criteria="composite_score",
    min_humanness=0.85
)

# Rank by developability
ranked = results.rank_by(criteria=["humanness", "binding_retention", "stability"])

Selection Criteria:

  • Highest humanness score (>85%)
  • Fewest back-mutations required (<6)
  • Low immunogenicity risk
  • Good developability profile

Pattern 3: Framework Template Comparison

Scenario: Compare different humanization strategies for lead candidate.

# Test multiple framework combinations
strategies = [
    {"vh": "IGHV1-2*02", "vl": "IGKV1-12*01", "name": "Template-A"},
    {"vh": "IGHV3-23*01", "vl": "IGKV3-20*01", "name": "Template-B"},
    {"vh": "IGHV4-34*01", "vl": "IGKV1-5*01", "name": "Template-C"}
]

comparison = humanizer.compare_strategies(
    murine_antibody=analysis,
    strategies=strategies,
    metrics=["homology", "back_mutations", "immunogenicity", "paratope_structure"]
)

comparison.generate_report("framework_comparison.pdf")

Comparison Metrics:

  • Sequence identity to human germline
  • Number and location of back-mutations
  • Predicted immunogenicity risk
  • CDR conformation preservation

Pattern 4: Intellectual Property Analysis

Scenario: Assess humanization for patent landscape analysis.

# Generate humanized variants
python scripts/main.py \
  --input murine_lead.json \
  --generate-variants 10 \
  --include-back-mutations \
  --output variants_for_ip.json

# Check novelty against patent databases
python scripts/patent_check.py \
  --sequences variants_for_ip.json \
  --databases [USPTO, EPO, WIPO] \
  --output novelty_report.pdf

IP Considerations:

  • Human framework combinations may be patented
  • CDR sequences determine antigen specificity
  • Back-mutation positions may be prior art
  • Document humanization rationale for filings

Complete Workflow Example

From murine hybridoma to therapeutic candidate:

# Step 1: Sequence analysis and CDR identification
python scripts/main.py \
  --vh $VH_SEQUENCE \
  --vl $VL_SEQUENCE \
  --scheme chothia \
  --output step1_analysis.json

# Step 2: Find best human frameworks
python scripts/main.py \
  --input step1_analysis.json \
  --find-frameworks \
  --top-n 5 \
  --output step2_frameworks.json

# Step 3: Score and rank candidates
python scripts/main.py \
  --input step2_frameworks.json \
  --score-candidates \
  --include-immunogenicity \
  --output step3_scored.json

# Step 4: Predict back-mutations
python scripts/main.py \
  --input step3_scored.json \
  --predict-back-mutations \
  --rationale \
  --output step4_backmutations.json

# Step 5: Generate final humanized sequences
python scripts/main.py \
  --input step4_backmutations.json \
  --generate-sequences \
  --format fasta \
  --output humanized_antibody.fasta

Python API:

from scripts.humanizer import AntibodyHumanizer
from scripts.scoring import HumanizationScorer
from scripts.backmutation import BackMutationPredictor

# Initialize pipeline
humanizer = AntibodyHumanizer()
scorer = HumanizationScorer()
bm_predictor = BackMutationPredictor()

# Step 1: Parse and analyze
antibody = humanizer.analyze_sequence(
    vh_sequence=murine_vh,
    vl_sequence=murine_vl,
    scheme="chothia"
)

# Step 2: Find human frameworks
candidates = humanizer.find_human_frameworks(
    antibody,
    top_n=5
)

# Step 3: Score candidates
for candidate in candidates:
    scores = scorer.calculate_scores(
        murine=antibody,
        humanized=candidate
    )
    candidate.composite_score = scores.weighted_score()

# Step 4: Select best and predict back-mutations
best = max(candidates, key=lambda x: x.composite_score)
back_mutations = bm_predictor.predict(
    murine=antibody,
    human_template=best
)

# Step 5: Generate final sequence
final_sequence = humanizer.generate_humanized_sequence(
    template=best,
    back_mutations=back_mutations,
    cdrs=antibody.cdr_regions
)

print(f"Humanized antibody generated:")
print(f"- Humanness: {best.humanness:.1%}")
print(f"- Back-mutations: {len(back_mutations)}")
print(f"- Risk level: {best.immunogenicity_risk}")

Quality Checklist

Input Quality:

  • [ ] VH and VL sequences complete (110-130 aa typical)
  • [ ] No ambiguous residues (B, Z, X)
  • [ ] Signal peptide removed
  • [ ] Constant region removed (variable region only)

Humanization Assessment:

  • [ ] CDR boundaries correctly identified
  • [ ] Human framework homology >80%
  • [ ] T20 score >75 (high humanness)
  • [ ] Vernier positions analyzed for back-mutations
  • [ ] Interface residues checked for packing

Output Validation:

  • [ ] Humanized sequence valid (no stop codons)
  • [ ] CDRs preserved exactly
  • [ ] Framework length conserved
  • [ ] Back-mutations documented with rationale
  • [ ] CRITICAL: Immunogenicity risk assessed

Before Experimental Work:

  • [ ] CRITICAL: Top 2-3 candidates selected for expression
  • [ ] Binding affinity to be tested (ELISA/Biacore)
  • [ ] Stability assessed (thermal/aggregation)
  • [ ] Immunogenicity in vitro assays planned

Common Pitfalls

Sequence Issues:

  • ❌ Incomplete sequences → Missing framework regions

- ✅ Ensure full VH/VL variable domains provided

  • ❌ Wrong numbering scheme → CDR boundaries incorrect

- ✅ Verify scheme matches experimental data source

  • ❌ Non-standard residues → Unusual amino acids

- ✅ Clean sequences; remove signal peptides

Design Issues:

  • ❌ Over-humanization → Losing antigen binding

- ✅ Don't exceed 85-90% humanness; retain critical residues

  • ❌ Ignoring back-mutations → Assuming 100% human framework works

- ✅ Always predict and test back-mutations

  • ❌ Single candidate only → No backup options

- ✅ Generate 2-3 candidates with different frameworks

Experimental Issues:

  • ❌ Skipping binding validation → Assuming in silico = in vivo

- ✅ Always confirm antigen binding experimentally

  • ❌ Ignoring developability → Aggregation or instability

- ✅ Check for problematic residues (unpaired cysteines, hydrophobic patches)

References

Available in references/ directory:

  • imgt_germline_database.md - Human germline gene reference sequences
  • cdr_numbering_schemes.md - Kabat, Chothia, IMGT comparison
  • humanization_case_studies.md - Successful therapeutic examples
  • vernier_positions_guide.md - Critical framework residues
  • immunogenicity_assessment.md - T-cell epitope prediction methods
  • patent_landscape.md - Humanization IP considerations

Scripts

Located in scripts/ directory:

  • main.py - CLI interface for humanization
  • humanizer.py - Core humanization engine
  • cdr_parser.py - CDR identification and numbering
  • framework_matcher.py - Human germline database search
  • scoring.py - Humanization quality assessment
  • backmutation.py - Critical residue prediction
  • batch_processor.py - Multiple antibody screening
  • structure_predictor.py - CDR conformation analysis

Limitations

  • Binding Prediction: Cannot accurately predict impact on antigen affinity
  • Developability: Limited prediction of aggregation or stability issues
  • Immunogenicity: In silico T-cell epitope prediction has false positives
  • Non-Standard Antibodies: May not handle camelid, shark, or engineered scaffolds
  • Experimental Validation Required: All predictions must be confirmed in vitro/vivo
  • Intellectual Property: Does not check for existing patent claims on sequences

Parameters

ParameterTypeDefaultRequiredDescription
--vhstring-NoMurine VH sequence (amino acids)
--vlstring-NoMurine VL sequence (amino acids)
--input, -istring-NoInput JSON file path
--name, -nstring""NoAntibody name
--output, -ostring-NoOutput file path
--format, -fstringjsonNoOutput format (json, fasta, csv)
--scheme, -sstringchothiaNoNumbering scheme (kabat, chothia, imgt)
--top-nint3NoNumber of best candidates to return

Usage

Basic Usage

# Humanize with direct sequence input
python scripts/main.py --vh "QVQLQQSGPELVKPGASVKMSCKAS..." --vl "DIQMTQSPSSLSASVGDRVTITC..." --name "MyAntibody"

# Use JSON input file
python scripts/main.py --input antibody.json --output results.json

# Use IMGT numbering scheme
python scripts/main.py --vh "SEQUENCE" --vl "SEQUENCE" --scheme imgt

Input JSON Format

{
  "vh_sequence": "QVQLQQSGPELVKPGASVKMSCKAS...",
  "vl_sequence": "DIQMTQSPSSLSASVGDRVTITC...",
  "name": "MyAntibody",
  "scheme": "chothia"
}

Risk Assessment

Risk IndicatorAssessmentLevel
Code ExecutionPython script executed locallyMedium
Network AccessNo external API callsLow
File System AccessRead input files, write output filesLow
Instruction TamperingStandard prompt guidelinesLow
Data ExposureOutput may contain proprietary sequencesMedium

Security Checklist

  • [x] No hardcoded credentials or API keys
  • [x] No unauthorized file system access (../)
  • [x] Input validation for sequences
  • [x] Prompt injection protections in place
  • [x] Error messages sanitized
  • [x] Output directory restricted to workspace
  • [x] Script execution in sandboxed environment

Prerequisites

# Python 3.7+
# No external packages required (uses standard library)

Evaluation Criteria

Success Metrics

  • [x] Successfully parses antibody sequences
  • [x] Identifies CDR regions correctly
  • [x] Matches human germline frameworks
  • [x] Predicts back-mutations
  • [x] Generates valid humanized sequences

Test Cases

  1. Basic Functionality: Humanize valid VH/VL sequences → Returns candidates
  2. Edge Case: Invalid sequence characters → Graceful error message
  3. File Input: Process JSON input → Correctly parses and outputs

Lifecycle Status

  • Current Stage: Draft
  • Next Review Date: 2026-03-06
  • Known Issues: None
  • Planned Improvements:

- Add T20 score database integration - Support for camelid and shark antibodies - Structure-based CDR prediction


🔬 Critical Note: Computational humanization is a design tool, not a substitute for experimental validation. Always express and test humanized candidates for binding affinity, specificity, stability, and immunogenicity before therapeutic development.

平台分布

OpenClaw

96.95%
按下载量换算1,605

安全审计

VirusTotal

通过

ClawScan

通过

Static analysis

通过

权限和风险

权限未标注

当前来源未能明确判断权限范围,默认进入异常复核队列。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。目前只有一个公开来源,建议同时核对源仓库。

继续浏览同类 Skills